Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Badesch

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Respiratory Medicine|January 23, 2010
Pulmonary hypertension in lung diseases: survey of beliefs and practice patternsOmar A Minai, Steven D Nathan, Nicholas S Hill, et al.
Respiratory Research|June 16, 2016
Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAHDeborah McCollister, Shannon Shaffer, David B Badesch, et al.
BMC Medical Research Methodology|May 21, 2022
Inference following multiple imputation for generalized additive models: an investigation of the median p-value rule with applications to the Pulmonary Hypertension Association Registry and Colorado COVID-19 hospitalization dataMatthew A Bolt, Samantha MaWhinney, Jack W Pattee, et al.
Mayo Clinic Proceedings|February 2, 2011
Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination SurveyCharles D Burger, Aimee J Foreman, Dave P Miller, et al.
Journal of the American College of Cardiology|June 15, 2004
Prostanoid therapy for pulmonary arterial hypertensionDavid B Badesch, Vallerie V McLaughlin, Marion Delcroix, et al.
Proceedings of the American Thoracic Society|July 16, 2008
Surrogate and combined end points in pulmonary arterial hypertensionCorey E Ventetuolo, Raymond L Benza, Andrew J Peacock, et al.
Chest|August 3, 2013
Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysisAdaani E Frost, David B Badesch, Dave P Miller, et al.
Chest|January 28, 2012
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL RegistryRaymond L Benza, Dave P Miller, Robyn J Barst, et al.
The Journal of Rheumatology|November 7, 2007
Sildenafil for pulmonary arterial hypertension associated with connective tissue diseaseDavid B Badesch, Nicholas S Hill, Gary Burgess, et al.
Chest|July 23, 2011
Portopulmonary hypertension: a report from the US-based REVEAL RegistryMichael J Krowka, Dave P Miller, Robyn J Barst, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Respiratory Medicine|January 23, 2010
Pulmonary hypertension in lung diseases: survey of beliefs and practice patternsOmar A Minai, Steven D Nathan, Nicholas S Hill, et al.
Respiratory Research|June 16, 2016
Development of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT®) questionnaire: a new patient-reported outcome instrument for PAHDeborah McCollister, Shannon Shaffer, David B Badesch, et al.
BMC Medical Research Methodology|May 21, 2022
Inference following multiple imputation for generalized additive models: an investigation of the median p-value rule with applications to the Pulmonary Hypertension Association Registry and Colorado COVID-19 hospitalization dataMatthew A Bolt, Samantha MaWhinney, Jack W Pattee, et al.
Mayo Clinic Proceedings|February 2, 2011
Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination SurveyCharles D Burger, Aimee J Foreman, Dave P Miller, et al.
Journal of the American College of Cardiology|June 15, 2004
Prostanoid therapy for pulmonary arterial hypertensionDavid B Badesch, Vallerie V McLaughlin, Marion Delcroix, et al.
Proceedings of the American Thoracic Society|July 16, 2008
Surrogate and combined end points in pulmonary arterial hypertensionCorey E Ventetuolo, Raymond L Benza, Andrew J Peacock, et al.
Chest|August 3, 2013
Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysisAdaani E Frost, David B Badesch, Dave P Miller, et al.
Chest|January 28, 2012
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL RegistryRaymond L Benza, Dave P Miller, Robyn J Barst, et al.
The Journal of Rheumatology|November 7, 2007
Sildenafil for pulmonary arterial hypertension associated with connective tissue diseaseDavid B Badesch, Nicholas S Hill, Gary Burgess, et al.
Chest|July 23, 2011
Portopulmonary hypertension: a report from the US-based REVEAL RegistryMichael J Krowka, Dave P Miller, Robyn J Barst, et al.
Pageof 9